GA
AGIO icon

Gateway Advisory’s Agios Pharmaceuticals AGIO Stock Holding History

Gateway Advisory’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,875
Closed -$208K – 36
2015
Q2 		$208K Buy
+1,875
New +$202K 0.09% 38

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Gateway Advisory's AGIO Position: Q3 2015 in Review

Gateway Advisory sold out of Agios Pharmaceuticals (AGIO) in Q3 2015, closing a stake of 1,875 shares — an estimated $208K sold.

Gateway Advisory first reported a position in AGIO in Q2 2015 and held it in 1 quarter. The position peaked at $208K in Q2 2015. 150 funds tracked by Wall St. Rank hold AGIO as of Q3 2015.

  • Gateway Advisory reported no remaining Agios Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Gateway Advisory sold 1,875 Agios Pharmaceuticals shares in Q3 2015, an estimated $208K.
  • Gateway Advisory first reported a position in Agios Pharmaceuticals in Q2 2015 and held it in 1 quarter.
  • Gateway Advisory's Agios Pharmaceuticals position peaked at $208K in Q2 2015.
  • 150 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2015.

Based on Gateway Advisory's 13F filing for Q3 2015, filed 6 Nov 2015.